Discover the complexities of hyperandrogenism, its causes, symptoms, treatment, and societal stigma impacting women's health ...

For nearly a century, biologists have relied on a simple rule to predict how microbes grow when food is scarce, a rule that ...

AINE Wood realised something was very wrong after spending hours Christmas shopping without a single urge to eat. The ...

Easing hot flashes, treating rare genetic diseases and a made-in-Canada vaccine among the year’s notable developments ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell transplant–associated thrombotic microangiopathy (TA-TMA) in adults and children aged ...

Breastfeeding a preterm baby is considered quite challenging A gynaecologist explains why breastfeeding is important for ...

As of Wednesday, December 24, Travere Therapeutics, Inc.’s TVTX share price has surged by 17.75%, which has investors questioning if this is right time to sell.

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ...

Winter brings cosy evenings and festive vibes, but it also marks the season of colds, coughs, and lowered immunity. As ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...